Southern Star Research (Australia)
An independent Australian contract research organization (CRO) specializing in early-phase clinical trials for small and mid-sized biotech, pharmaceutical, and medical device companies across Australia and APAC.
Last updated September 27, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Southern Star Research is an independent, mid-sized contract research organization (CRO) based in Gordon, Australia, that positions itself as a strategic Australian partner for clinical trials. The company describes itself as "The Strategic Australian CRO for Successful Clinical Trials," offering senior-level expertise and hands-on continuity in Australia and the Asia-Pacific region. Its core focus is guiding small and mid-sized biotech, pharmaceutical, and medical device companies through complex early-phase clinical development, from first-in-human (FIH) studies through Phase I and Phase II, and onward into pivotal Phase III when programs require it. The company markets what it calls the "sweet spot" advantage: substantial enough to provide comprehensive, globally recognized services, yet agile and client-focused for personalized engagement. Its stated philosophy emphasizes intellectually engaged partnership, embedded quality, and principled action, treating each protocol as a problem worth solving rather than a checklist to execute. Southern Star Research presents itself as a trusted advisor rather than a passive service provider, sharing knowledge and engaging in collaborative decision-making with sponsors. Southern Star Research leverages Australia's and the broader APAC region's clinical trial landscape, which it says offers cost efficiency up to 60% lower than the US or EU, supported by R&D tax incentives; a stable, globally aligned regulatory environment; rapid regulatory pathways with timelines as short as 4–8 weeks from submission to site initiation; and data accepted by major international regulatory bodies including the FDA, EMA, PMDA, and Health Canada. The company provides end-to-end clinical trial operational services, including early strategic and study design support, study start-up, clinical operations, biometrics, safety and medical monitoring, medical writing, and quality assurance. It also offers specialized trial rescue services for stalled trials. As an independent mid-sized CRO, Southern Star Research is privately held and does not appear to be part of a large global CRO network. Its headquarters is listed in Gordon, Australia, and it operates across Australia and the Asia-Pacific. The company's therapeutic and operational expertise is aimed at generating regulator-ready, investor-grade data that de-risks assets for future funding, licensing, or commercial sale.
History
Southern Star Research was founded by industry pioneers, according to the company's own account, driven by a commitment to intellectually engaged partnership, embedded quality, and principled action. This foundational philosophy continues to shape its culture and approach to client relationships. The company established itself as an independent, mid-sized contract research organization (CRO) based in Gordon, Australia, focused on serving small and mid-sized biotech, pharmaceutical, and medical device companies. From its base in Australia, Southern Star Research built its practice around the country's clinical trial environment, which it describes as offering significant advantages: cost efficiency up to 60% lower than the US or EU, supported by R&D tax incentives; a stable, globally aligned regulatory landscape; rapid regulatory pathways with timelines as short as 4–8 weeks from submission to site initiation; and data accepted by major international regulators including the FDA, EMA, PMDA, and Health Canada. The company positioned itself as a gateway to the Asia-Pacific region for biotech sponsors. Southern Star Research developed a service model centered on early-phase clinical development, specializing in first-in-human (FIH) and Phase I/II trials, while maintaining the infrastructure to support Phase IIb and Phase III programs. Its operational services span study design and protocol de-risking, study start-up leveraging Australia's CTN scheme and Human Research Ethics Committees (HREC), clinical operations, biometrics, safety and medical monitoring, medical writing, and quality assurance. The company also offers trial rescue services for stalled trials. The company emphasizes a senior-heavy, hands-on approach, with teams therapeutically matched to clients and active medical monitors and former Principal Investigators involved in protocol review. It markets its ability to generate regulator-ready, investor-grade data that de-risks assets for future funding, licensing, or commercial sale. As of the available evidence, Southern Star Research remains an independent, privately held CRO operating across Australia and the Asia-Pacific, with no indication of acquisition by or merger into a larger global CRO network.
Products and positioning
Independent mid-sized Australian CRO offering a "sweet spot" of comprehensive global services with agile, client-focused engagement, specializing in early-phase trials for small and mid-sized biotechs.
Early strategic and study design support
Protocol interrogation and de-risking involving active medical monitors and former Principal Investigators to ensure studies are operationally executable.
Study start-up
Leverages Australia's CTN scheme and deep familiarity with Human Research Ethics Committees (HREC) to compress the activation window and achieve rapid site activation.
Clinical operations
Senior-heavy clinical operations teams therapeutically matched to sponsors, providing ownership that drives study velocity.
Biometrics
Data management and statistical services for clinical trials.
Safety and medical monitoring
Medical oversight and safety management throughout the trial lifecycle.
Medical writing
Regulatory and clinical documentation services.
Quality assurance
Embedded quality and rigor to ensure compliance and data integrity.
Trial rescue
Specialized operational recovery for stalled clinical trials.
Sources5 sources
- 1Strategic Australian CRO for Biotechs | Southern Star Researchsouthernstarresearch.com
- 2Your early-phase partner - Southern Star Researchsouthernstarresearch.com
- 3Clinical Trials - Southern Star Researchsouthernstarresearch.com
- 4CRO Operational Services - Southern Star Researchsouthernstarresearch.com
- 5Southern Star Research (Australia) - Wikidatawikidata.org
Cite this profile: Cite the canonical profile. /brand-wiki/southern-star-research-australia · Editorial policy · How profiles are compiled